Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
138 Results Found
AHA Letter to Senate Subcommittee Leadership on Appropriations Priorities for FY 2025
AHA Senate letter regarding funding for health care programs for fiscal year (FY) 2025.
AHA Comments on the Remanufacturing of Medical Devices, Draft Guidance for Industry and FDA Staff
AHA comments on the Remanufacturing of Medical Devices, Draft Guidance for Industry and Food and Drug Administration Staff.
AHRMM LUC Comments to the FDA’s Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices
The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices. They recommend that information related to all Class I Medical Devices be included in the GUDID without exception.
AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)
Letter/Comment
On November 21, 2013, AHRMM submitted electronically
AHA, Others Urge Congress to Reauthorize Health Care Preparedness Law
Nearly 50 organizations, including the AHA, urge congressional leaders to reauthorize before yearend the Pandemic and All-Hazards Preparedness Act, which expired Sept. 30.
AHRMM Statement on Comparative Effectiveness
Letter/Comment
AHRMM supports the concept and use of Comparative Effectiveness Research (CER) to provide evidence-based data to help inform purchasing decisions.
AHA Comments on Energy and Commerce Committee's Drug Shortages Discussion Draft
AHA's comments on Energy and Commerce Committee Chair Rodgers’ drug shortages discussion draft.
AHA Responds to CMS' Episode Based Payment Model Request for Information
AHA provides feedback on CMS' Episode Based Payment request for information.
AHA Letter of Support for the Drug Shortage Prevention Act of 2023
The Drug Shortage Prevention Act would require manufacturers to notify the Food and Drug Administration (FDA) of increased demand of covered drugs. The AHA believes the requirement that manufacturers notify the FDA of increased demand for critical drugs will be an integral tool for shoring up the supply chain.